Literature DB >> 21448747

A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.

Christina Avanti1, Jean-Pierre Amorij, Dewi Setyaningsih, Andrea Hawe, Wim Jiskoot, Jan Visser, Alexej Kedrov, Arnold J M Driessen, Wouter L J Hinrichs, Henderik W Frijlink.   

Abstract

In the current study, the effect of metal ions in combination with buffers (citrate, acetate, pH 4.5) on the stability of aqueous solutions of oxytocin was investigated. Both monovalent metal ions (Na(+) and K(+)) and divalent metal ions (Ca(2+), Mg(2+), and Zn(2+)) were tested all as chloride salts. The effect of combinations of buffers and metal ions on the stability of aqueous oxytocin solutions was determined by RP-HPLC and HP-SEC after 4 weeks of storage at either 4°C or 55°C. Addition of sodium or potassium ions to acetate- or citrate-buffered solutions did not increase stability, nor did the addition of divalent metal ions to acetate buffer. However, the stability of aqueous oxytocin in aqueous formulations was improved in the presence of 5 and 10 mM citrate buffer in combination with at least 2 mM CaCl(2), MgCl(2), or ZnCl(2) and depended on the divalent metal ion concentration. Isothermal titration calorimetric measurements were predictive for the stabilization effects observed during the stability study. Formulations in citrate buffer that had an improved stability displayed a strong interaction between oxytocin and Ca(2+), Mg(2+), or Zn(2+), while formulations in acetate buffer did not. In conclusion, our study shows that divalent metal ions in combination with citrate buffer strongly improved the stability of oxytocin in aqueous solutions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448747      PMCID: PMC3085697          DOI: 10.1208/s12248-011-9268-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  20 in total

1.  Protein deamidation.

Authors:  Noah E Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  RESPONSES OF NERVE-FREE VESSELS TO VASOACTIVE AMINES AND POLYPEPTIDES.

Authors:  A V SOMLYO; C Y WOO; A P SOMLYO
Journal:  Am J Physiol       Date:  1965-04

3.  Oxytocin-receptor binding: why divalent metals are essential.

Authors:  Dengfeng Liu; Alexandra B Seuthe; Oli T Ehrler; Xiaohua Zhang; Thomas Wyttenbach; Jeffrey F Hsu; Michael T Bowers
Journal:  J Am Chem Soc       Date:  2005-02-23       Impact factor: 15.419

4.  Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV.

Authors:  W Grimm
Journal:  Drug Dev Ind Pharm       Date:  1998-04       Impact factor: 3.225

Review 5.  Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides.

Authors:  Hongqian Yang; Roman A Zubarev
Journal:  Electrophoresis       Date:  2010-06       Impact factor: 3.535

6.  Influence of oxytocin on renal hemodynamics and electrolyte and water excretion.

Authors:  K P Conrad; M Gellai; W G North; H Valtin
Journal:  Am J Physiol       Date:  1986-08

7.  Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon.

Authors:  Anjali B Joshi; Monali Sawai; William R Kearney; Lee E Kirsch
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

8.  Stabilization of a polypeptide in non-aqueous solvents.

Authors:  Wei Wang; Sheryl Martin-Moe; Clark Pan; Laszlo Musza; Y John Wang
Journal:  Int J Pharm       Date:  2007-09-15       Impact factor: 5.875

9.  Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.

Authors:  Andrea Hawe; Robert Poole; Stefan Romeijn; Piotr Kasper; Rob van der Heijden; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-04-03       Impact factor: 4.200

10.  Extended stability of oxytocin in common infusion solutions.

Authors:  Lawrence A Trissel; Yanping Zhang; Kate Douglas; Eric Kastango
Journal:  Int J Pharm Compd       Date:  2006 Mar-Apr
View more
  7 in total

Review 1.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 2.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

3.  Rapid Absorption of Dry-Powder Intranasal Oxytocin.

Authors:  Mikolaj Milewski; Adrian Goodey; Dinah Lee; Eric Rimmer; Robert Saklatvala; Shuzo Koyama; Mic Iwashima; Shunji Haruta
Journal:  Pharm Res       Date:  2016-05-18       Impact factor: 4.200

4.  Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.

Authors:  Karine Fabio; Kieran Curley; Joseph Guarneri; Benoit Adamo; Brendan Laurenzi; Marshall Grant; Robin Offord; Kelly Kraft; Andrea Leone-Bay
Journal:  AAPS PharmSciTech       Date:  2015-03-17       Impact factor: 3.246

5.  17β-estradiol upregulates oxytocin and the oxytocin receptor in C2C12 myotubes.

Authors:  Enrica Berio; Sara Divari; Laura Starvaggi Cucuzza; Bartolomeo Biolatti; Francesca Tiziana Cannizzo
Journal:  PeerJ       Date:  2017-03-30       Impact factor: 2.984

6.  Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries.

Authors:  Mattias Malm; Ingbritt Madsen; Johan Kjellström
Journal:  J Pept Sci       Date:  2018-04-27       Impact factor: 1.905

7.  Stability of Oxytocin Preparations in Malawi and Rwanda: Stabilizing Effect of Chlorobutanol.

Authors:  Nhomsai Hagen; Thomas Bizimana; Pierre Claver Kayumba; Felix Khuluza; Lutz Heide
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.